Cargando…
Cellular and complement-dependent cytotoxicity of Ep-CAM-specific monoclonal antibody MT201 against breast cancer cell lines
MT201 is a fully human monoclonal IgG1 antibody with moderate affinity for epithelial cell adhesion molecule (Ep-CAM) being clinically developed for the treatment of carcinomas. Like many other clinically validated IgG1 monoclonal antibodies, MT201 primarily acts by antibody-dependent cellular cytot...
Autores principales: | Prang, N, Preithner, S, Brischwein, K, Göster, P, Wöppel, A, Müller, J, Steiger, C, Peters, M, Baeuerle, P A, da Silva, A J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361858/ https://www.ncbi.nlm.nih.gov/pubmed/15655555 http://dx.doi.org/10.1038/sj.bjc.6602310 |
Ejemplares similares
-
Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers
por: Went, P, et al.
Publicado: (2006) -
EpCAM (CD326) finding its role in cancer
por: Baeuerle, P A, et al.
Publicado: (2007) -
EpCAM (CD326) finding its role in cancer
por: Baeuerle, P A, et al.
Publicado: (2007) -
Expression of EpCAM(MF) and EpCAM(MT) variants in human carcinomas
por: Fong, Dominic, et al.
Publicado: (2014) -
Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential
por: Bryan, R T, et al.
Publicado: (2014)